137 related articles for article (PubMed ID: 3003715)
1. Safety, infectivity, transmissibility and immunogenicity of rhesus rotavirus vaccine (MMU 18006) in infants.
Losonsky GA; Rennels MB; Kapikian AZ; Midthun K; Ferra PJ; Fortier DN; Hoffman KM; Baig A; Levine MM
Pediatr Infect Dis; 1986; 5(1):25-9. PubMed ID: 3003715
[TBL] [Abstract][Full Text] [Related]
2. Effect of dose and a comparison of measures of vaccine take for oral rhesus rotavirus vaccine. The Maryland Clinical Studies Group.
Pichichero ME; Losonsky GA; Rennels MB; Disney FA; Green JL; Francis AB; Marsocci SM
Pediatr Infect Dis J; 1990 May; 9(5):339-44. PubMed ID: 2162027
[TBL] [Abstract][Full Text] [Related]
3. Protective efficacy against serotype 1 rotavirus diarrhea by live oral rhesus-human reassortant rotavirus vaccines with human rotavirus VP7 serotype 1 or 2 specificity.
Vesikari T; Ruuska T; Green KY; Flores J; Kapikian AZ
Pediatr Infect Dis J; 1992 Jul; 11(7):535-42. PubMed ID: 1326741
[TBL] [Abstract][Full Text] [Related]
4. Comparison of immunogenicity and efficacy of rhesus rotavirus reassortant vaccines in breastfed and nonbreastfed children. US Rotavirus Vaccine Efficacy Group.
Rennels MB; Wasserman SS; Glass RI; Keane VA
Pediatrics; 1995 Dec; 96(6):1132-6. PubMed ID: 7491235
[TBL] [Abstract][Full Text] [Related]
5. Vaccination of Thai infants with rhesus-human reassortant tetravalent oral rotavirus vaccine.
Simasathien S; Migasena S; Samakoses R; Pitisuttitham P; Sangaroon P; Aree C; Bishop R; Bugg H; Davidson BL; Vesikari T
Pediatr Infect Dis J; 1994 Jul; 13(7):590-6. PubMed ID: 7970945
[TBL] [Abstract][Full Text] [Related]
6. Symptoms associated with rhesus-human reassortant rotavirus vaccine in infants.
Joensuu J; Koskenniemi E; Vesikari T
Pediatr Infect Dis J; 1998 Apr; 17(4):334-40. PubMed ID: 9576390
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity, safety and protective efficacy of one dose of the rhesus rotavirus vaccine and serotype 1 and 2 human-rhesus rotavirus reassortants in children from Lima, Peru.
Lanata CF; Black RE; Flores J; Lazo F; Butron B; Linares A; Huapaya A; Ventura G; Gil A; Kapikian AZ
Vaccine; 1996 Feb; 14(3):237-43. PubMed ID: 8920706
[TBL] [Abstract][Full Text] [Related]
8. Field trial of rhesus rotavirus vaccine in infants.
Christy C; Madore HP; Pichichero ME; Gala C; Pincus P; Vosefski D; Hoshino Y; Kapikian A; Dolin R
Pediatr Infect Dis J; 1988 Sep; 7(9):645-50. PubMed ID: 2845349
[TBL] [Abstract][Full Text] [Related]
9. Protection against severe rotavirus diarrhoea by rhesus rotavirus vaccine in Venezuelan infants.
Flores J; Perez-Schael I; Gonzalez M; Garcia D; Perez M; Daoud N; Cunto W; Chanock RM; Kapikian AZ
Lancet; 1987 Apr; 1(8538):882-4. PubMed ID: 2882289
[TBL] [Abstract][Full Text] [Related]
10. Rhesus Rotavirus candidate vaccine. Clinical trial in children vaccinated between 2 and 5 months of age.
Vesikari T; Rautanen T; Varis T; Beards GM; Kapikian AZ
Am J Dis Child; 1990 Mar; 144(3):285-9. PubMed ID: 2154925
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity, safety and efficacy of tetravalent rhesus-human, reassortant rotavirus vaccine in Belém, Brazil.
Linhares AC; Gabbay YB; Mascarenhas JD; de Freitas RB; Oliveira CS; Bellesi N; Monteiro TA; Lins-Lainson Z; Ramos FL; Valente SA
Bull World Health Organ; 1996; 74(5):491-500. PubMed ID: 9002329
[TBL] [Abstract][Full Text] [Related]
12. A comparative trial of rhesus monkey (RRV-1) and bovine (RIT 4237) oral rotavirus vaccines in young children.
Vesikari T; Kapikian AZ; Delem A; Zissis G
J Infect Dis; 1986 May; 153(5):832-9. PubMed ID: 3009634
[TBL] [Abstract][Full Text] [Related]
13. Safety and immunogenicity of tetravalent rhesus-based rotavirus vaccine in Bangladesh.
Bresee JS; El Arifeen S; Azim T; Chakraborty J; Mounts AW; Podder G; Gentsch JR; Ward RL; Black R; Glass RI; Yunus M
Pediatr Infect Dis J; 2001 Dec; 20(12):1136-43. PubMed ID: 11740320
[TBL] [Abstract][Full Text] [Related]
14. An efficacy trial of the rhesus rotavirus vaccine in Maryland. The Clinical Study Group.
Rennels MB; Losonsky GA; Young AE; Shindledecker CL; Kapikian AZ; Levine MM
Am J Dis Child; 1990 May; 144(5):601-4. PubMed ID: 2330930
[TBL] [Abstract][Full Text] [Related]
15. Safety, immunogenicity, and protective efficacy of one and three doses of the tetravalent rhesus rotavirus vaccine in infants in Lima, Peru.
Lanata CF; Midthun K; Black RE; Butron B; Huapaya A; Penny ME; Ventura G; Gil A; Jett-Goheen M; Davidson BL
J Infect Dis; 1996 Aug; 174(2):268-75. PubMed ID: 8699054
[TBL] [Abstract][Full Text] [Related]
16. Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis.
Joensuu J; Koskenniemi E; Pang XL; Vesikari T
Lancet; 1997 Oct; 350(9086):1205-9. PubMed ID: 9652561
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous administration of rhesus rotavirus vaccine and oral poliovirus vaccine: immunogenicity and reactogenicity.
Ho MS; Floyd RL; Glass RI; Pallansch MA; Jones B; Hamby B; Woods P; Penaranda ME; Kapikian AZ; Bohan G
Pediatr Infect Dis J; 1989 Oct; 8(10):692-6. PubMed ID: 2554244
[TBL] [Abstract][Full Text] [Related]
18. Neonatal administration of rhesus rotavirus tetravalent vaccine.
Vesikari T; Karvonen A; Forrest BD; Hoshino Y; Chanock RM; Kapikian AZ
Pediatr Infect Dis J; 2006 Feb; 25(2):118-22. PubMed ID: 16462287
[TBL] [Abstract][Full Text] [Related]
19. Comparative evaluation of reactogenicity and immunogenicity of two dosages of oral tetravalent rhesus rotavirus vaccine. US Rhesus Rotavirus Vaccine Study Group.
Dennehy PH; Rodgers GC; Ward RL; Markwick AJ; Mack M; Zito ET
Pediatr Infect Dis J; 1996 Nov; 15(11):1012-8. PubMed ID: 8933551
[TBL] [Abstract][Full Text] [Related]
20. Clinical studies of a quadrivalent rotavirus vaccine in Venezuelan infants.
Perez-Schael I; Blanco M; Vilar M; Garcia D; White L; Gonzalez R; Kapikian AZ; Flores J
J Clin Microbiol; 1990 Mar; 28(3):553-8. PubMed ID: 2157737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
